Baillie Gifford & CO Vir Biotechnology, Inc. Transaction History

Baillie Gifford & CO

$131 Billion
Q3 2024

A detailed history of Baillie Gifford & CO transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 2,383,029 shares of VIR stock, worth $18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,383,029

Previous 3,921,242 39.23%

Holding current value

$18 Million

Previous $34.9 Million 48.86%

% of portfolio

0.01%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$7.26 - $10.7 $11.2 Million - $16.5 Million	-1,538,213 Reduced 39.23%	2,383,029 $17.8 Million
Q2 2024 Jul 25, 2024	SELL	$7.63 - $12.66 $197,029 - $326,919	-25,823 Reduced 0.65%	3,921,242 $34.9 Million
Q1 2024 May 01, 2024	SELL	$8.6 - $11.9 $158,962 - $219,959	-18,484 Reduced 0.47%	3,947,065 $40 Million
Q4 2023 Jan 26, 2024	SELL	$7.76 - $10.29 $46,730 - $61,966	-6,022 Reduced 0.15%	3,965,549 $39.9 Million
Q3 2023 Nov 13, 2023	SELL	$9.14 - $24.62 $108,528 - $292,337	-11,874 Reduced 0.3%	3,971,571 $37.2 Million
Q2 2023 Jul 28, 2023	SELL	$23.2 - $27.29 $59,879 - $70,435	-2,581 Reduced 0.06%	3,983,445 $97.7 Million
Q1 2023 May 03, 2023	BUY	$22.26 - $30.85 $31,720 - $43,961	1,425 Added 0.04%	3,986,026 $92.8 Million
Q4 2022 Jan 24, 2023	BUY	$19.96 - $28.22 $118,642 - $167,739	5,944 Added 0.15%	3,984,601 $101 Million
Q3 2022 Oct 27, 2022	BUY	$18.26 - $31.1 $872,919 - $1.49 Million	47,805 Added 1.22%	3,978,657 $76.7 Million
Q2 2022 Aug 08, 2022	SELL	$19.08 - $26.7 $311,156 - $435,423	-16,308 Reduced 0.41%	3,930,852 $100 Million
Q1 2022 May 05, 2022	BUY	$21.19 - $40.01 $670,854 - $1.27 Million	31,659 Added 0.81%	3,947,160 $102 Million
Q4 2021 Jan 20, 2022	BUY	$30.97 - $54.03 $489,604 - $854,160	15,809 Added 0.41%	3,915,501 $164 Million
Q3 2021 Oct 19, 2021	BUY	$34.9 - $54.54 $1.75 Million - $2.74 Million	50,183 Added 1.3%	3,899,692 $170 Million
Q2 2021 Aug 02, 2021	BUY	$38.75 - $51.0 $1.25 Million - $1.65 Million	32,361 Added 0.85%	3,849,509 $182 Million
Q1 2021 May 06, 2021	BUY	$26.34 - $83.07 $1.9 Million - $6 Million	72,200 Added 1.93%	3,817,148 $196 Million
Q4 2020 Feb 10, 2021	BUY	$25.51 - $43.38 $741,320 - $1.26 Million	29,060 Added 0.78%	3,744,948 $100 Million
Q3 2020 Nov 12, 2020	BUY	$28.28 - $53.6 $7.15 Million - $13.5 Million	252,686 Added 7.3%	3,715,888 $128 Million
Q2 2020 Aug 12, 2020	BUY	$27.89 - $47.86 $93 Million - $160 Million	3,333,333 Added 2566.69%	3,463,202 $142 Million
Q1 2020 May 08, 2020	SELL	$12.04 - $60.2 $4.46 Million - $22.3 Million	-370,131 Reduced 74.03%	129,869 $4.45 Million
Q4 2019 Feb 10, 2020	BUY	$11.83 - $15.85 $5.92 Million - $7.93 Million	500,000 New	500,000 $6.29 Million

Others Institutions Holding VIR

# of Institutions

219

Shares Held

87.4M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account

Baillie Gifford & CO Vir Biotechnology, Inc. Transaction History